TL;DR
How clinicians discuss growth hormone axis pathways without naming restricted peptide SKUs publicly.
Growth hormone axis basics
Growth hormone and IGF-1 influence body composition, recovery, and tissue maintenance. Levels fall with age and poor sleep.
Public educational content uses growth axis pathway language rather than consumer peptide merchandising.
Sermorelin as an example
Sermorelin may be prescribed as a growth hormone-releasing alternative when a licensed healthcare provider determines appropriateness. Compounded sermorelin is not an FDA-approved drug product.
Monitoring and candidacy screening are mandatory. No performance guarantees.
Prescription gating
Growth hormone secretagogues are prescription treatments, available only when a licensed provider finds them clinically appropriate.
Educational only. Not an offer of therapy.
Key takeaways
- Growth hormone and IGF-1 influence body composition, recovery, and tissue maintenance. Levels fall with age and poor sleep.
- Sermorelin may be prescribed as a growth hormone-releasing alternative when a licensed healthcare provider determines appropriateness. Compounded sermorelin is not an FDA-approved drug product.
- Growth hormone secretagogues are prescription treatments, available only when a licensed provider finds them clinically appropriate.
Map your healthspan & longevity starting point
Twelve questions about your goals and habits, scored from your answers alone. It is not a measurement or a diagnosis, and it does not prescribe or guarantee access to treatment.
Begin assessmentRelated treatments: Sermorelin